GDF2 and Cirrhosis: In contrast, analysis of distinct transcriptomic datasets from those mentioned above revealed that hepatic BMP9 mRNA expression is decreased in several human liver diseases including cirrhosis, NASH (non-alcoholic steato hepatitis) and hepatocarcinomas [14].